หน้าแรก
ค้นหา
Breast Cancer: Adding Pertuzumab as a Neoadjuvant Treatment Option
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
แสดงข้อมูลเพิ่มเติม 1
Breast Cancer: Adding Pertuzumab as a Neoadjuvant Treatment Option
Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer
Dr. Tripathy on Neoadjuvant Treatment Strategies in HER2+ Breast Cancer
Dr. Pegram Discusses Adjuvant Pertuzumab in HER2+ Breast Cancer
The APHINITY Trial
HER2CLIMB-05: tucatinib + trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic BC
Neoadjuvant Therapy for HER2+ Breast Cancer
MBN2021 - Breast and Axillary management after neoadjuvant treatments
Neoadjuvant Treatment Strategies for HER2-Positive Breast Cancer
Results of the Phase III APHINITY Trial in HER2-Positive Breast Cancer
Dr. Crew on the APHINITY Trial Results in HER2+ Breast Cancer
Dr. Tolaney on the Neoadjuvant Therapy for HER2-Positive Breast Cancer
Surgery Always Needed for Neoadjuvant Chemotherapy?
Dual HER2 blockade in patients with HER2-positive breast cancer after pCR
Adjuvant Therapy for Early-Stage HER2-Positive Breast Cancer
Patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast MR imaging
HER-2+ Breast Cancer - Russell
Pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
Results of the APHINITY Trial in HER2-Positive Breast Cancer
Case 1: Approach to Early Stage, HER2+ Breast Cancer